BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6175933)

  • 41. Vindesine in head and neck cancer. A Southwest Oncology Group Phase II pilot study.
    Haas CD; Fabian CJ; Stephens RL; Kish J
    Invest New Drugs; 1983; 1(4):339-40. PubMed ID: 6678881
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma.
    Moseley HS; Sasaki T; McConnell DB; Merhoff GC; Wilson WL; Grage TB; Wiess AJ; Fletcher WS
    J Surg Oncol; 1976; 8(1):35-42. PubMed ID: 55523
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combination chemotherapy of head and neck cancer.
    Holoye PY; Byers RM; Gard DA; Goepfert H; Guillamondegui OM; Jesse RH
    Cancer; 1978 Oct; 42(4):1661-9. PubMed ID: 81714
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: a phase II randomized study.
    Caponigro F; Rosati G; De Rosa P; Avallone A; De Rosa V; De Lucia L; Comella P; Comella G
    Oncology; 2002; 63(3):232-8. PubMed ID: 12381902
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment.
    Kris MG; Gralla RJ; Kalman LA; Kelsen DP; Casper ES; Burke MT; Groshen S; Cibas IR; Bagin R; Heelan RT
    Cancer Treat Rep; 1985 Apr; 69(4):387-95. PubMed ID: 3888388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination of mitomycin, vindesine, and cisplatin in the treatment of head and neck squamous cell carcinoma.
    Leyvraz S; Barrelet L; Savary M; Bernasconi S
    Cancer Treat Rep; 1987 Jan; 71(1):81-2. PubMed ID: 3791271
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Phase II trial of vindesine in advanced head and neck cancer.
    Cheng E; Young CW; Wittes RE
    Cancer Treat Rep; 1980; 64(10-11):1141-2. PubMed ID: 7459901
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Raafat J; Oster MW
    Cancer Treat Rep; 1980 Jan; 64(1):187-9. PubMed ID: 6155209
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cisplatin, vindesine, and bleomycin (DVB) combination chemotherapy for esophageal carcinoma.
    Kelsen DP; Bains M; Chapman R; Golbey R
    Cancer Treat Rep; 1981; 65(9-10):781-5. PubMed ID: 6168370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination of cis-platinum, oncovin, and bleomycin (COB) prior to surgery and/or radiotherapy in advanced untreated epidermoid cancer of the head and neck.
    Peppard SB; Al-Sarraf M; Powers WE; Loh JK; Weaver AW
    Laryngoscope; 1980 Aug; 90(8 Pt 1):1273-80. PubMed ID: 6157067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination chemotherapy with vincristine, bleomycin, and methotrexate for advanced head and neck cancers.
    Woods RL; Stewart J; Fox RM; Tattersall MH
    Cancer Treat Rep; 1979; 63(11-12):1997-9. PubMed ID: 93514
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Primary chemotherapy of advanced squamous epithelial carcinomas of the head and neck].
    Bruntsch U; Hiller T; Wandt H; Wolff L; Theissing J; Gallmeier WM
    Dtsch Med Wochenschr; 1985 Dec; 110(49):1889-92. PubMed ID: 2415315
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Preoperative chemotherapy of squamous cell carcinoma of the head and neck with V-T-M schedule (author's transl)].
    Ruffmann R; Seifert R; Ross H; Haass HG
    Laryngol Rhinol Otol (Stuttg); 1981 May; 60(5):271-4. PubMed ID: 6164894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sequential combination chemotherapy for advanced, recurrent, squamous carcinoma of the head and neck.
    Livingston RB; Einhorn LH; Burgess MA; Gottlieb JA
    Cancer Treat Rep; 1976 Jan; 60(1):103-5. PubMed ID: 63330
    [No Abstract]   [Full Text] [Related]  

  • 56. Effective outpatient combination chemotherapy for advanced cancer of the head and neck.
    Chiuten D; Vogl SE; Kaplan BH; Greenwald E
    Surg Gynecol Obstet; 1980 Nov; 151(5):659-62. PubMed ID: 6159692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changing role of chemotherapy in treatment of head and neck cancer.
    Mead GM; Jacobs C
    Am J Med; 1982 Oct; 73(4):582-95. PubMed ID: 6181680
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential combination chemotherapy for advanced squamous cell carcinoma of the head and neck.
    Lester EP; Kinnealey A; Matz GJ
    Laryngoscope; 1979 Dec; 89(12):1921-9. PubMed ID: 92740
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Combination chemotherapy of esophageal carcinoma using cisplatin, vindesine, and bleomycin.
    Kelsen DP; Bains M; Hilaris B; Chapman R; McCormack P; Alexander J; Hopfan S; Martini N
    Cancer; 1982 Mar; 49(6):1174-7. PubMed ID: 6174199
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loco-regional localization pattern of head and neck tumors treated with general chemotherapy (methotrexate and bleomycin).
    Calciati A; Bumma C; La Grotta G; Gino GC; Falda M
    Panminerva Med; 1976; 18(5-6):177-9. PubMed ID: 57586
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.